share_log

Biogen, Eli Lilly And Some Other Big Stocks Moving Higher In Today's Pre-Market Session

Biogen, Eli Lilly And Some Other Big Stocks Moving Higher In Today's Pre-Market Session

Biogen，Eli Lilly和其他一些大型股票在今天的盤前交易時段走高
Benzinga Real-time News ·  2022/09/28 18:16

U.S. stock futures traded lower this morning. Here are some big stocks moving higher in today's pre-market trading session.

今天上午，美國股指期貨走低。以下是今日盤前交易時段一些大盤股走高。

  • Biogen Inc. (NASDAQ:BIIB) shares rose 39.7% to $276.32 in pre-market trading. Biogen and Eisai Co. announced late Tuesday positive results from a late-stage study of their Alzheimer's treatment candidate.
  • Prothena Corporation plc (NASDAQ:PRTA) rose 37.4% to $42.50 in pre-market trading in sympathy with Biogen.
  • MorphoSys AG (NASDAQ:MOR) rose 17.7% to $5.24 in pre-market trading.
  • Cassava Sciences, Inc. (NASDAQ:SAVA) rose 10.2% to $50.90 in pre-market trading. Shares of companies with potential Alzheimer's treatments trading higher premarket in sympathy with Biogen.
  • Eli Lilly and Company (NYSE:LLY) rose 7.7% to $335.00 in pre-market trading. Shares of companies with potential Alzheimer's treatments trading higher premarket in sympathy with Biogen.
  • Alaunos Therapeutics, Inc. (NASDAQ:TRCT) gained 6.7% to $2.22 in pre-market trading after the company announced it will discuss the complete Phase 1 portion of the gavo-cel Phase 1/2 clinical trial for mesothelin-expressing solid tumors on Wednesday, September 28th.
  • Rumble Inc. (NASDAQ:RUM) gained 6.3% to $12.39 in pre-market trading after dropping more than 4% on Tuesday.
  • 生物遺傳公司納斯達克(BIIB)股價在盤前交易中上漲39.7%，至276.32美元。生物遺傳研究公司和衞材公司週二晚些時候宣佈，他們的阿爾茨海默氏症候選治療方案的後期研究取得了積極的結果。
  • 普羅塞納公司納斯達克(Sequoia Capital：PRTA)在盤前交易中上漲37.4%，至42.5美元，對生物遺傳研究公司表示同情。
  • Morphosys公司納斯達克(Alipay：MOR)在盤前交易中上漲17.7%，至5.24美元。
  • 木薯科學公司納斯達克(Sava)在盤前交易中上漲10.2%，至50.9美元。擁有潛在阿爾茨海默氏症治療藥物的公司的股價在盤前交易走高，對Biogen表示同情。
  • 禮來公司(紐約證券交易所代碼：LLY)在盤前交易中上漲7.7%，至335.00美元。擁有潛在阿爾茨海默氏症治療藥物的公司的股價在盤前交易走高，對Biogen表示同情。
  • ALaunos治療公司納斯達克(Sequoia Capital：TRCT)在盤前交易中上漲6.7%，至2.22美元，此前該公司宣佈將於9月28日(星期三)討論Gavo-cel 1/2期臨牀試驗的完整第一階段，以治療表達間充質蛋白的實體腫瘤。
  • 隆博公司。納斯達克(Tmall：朗姆酒)在週二下跌超過4%後，在盤前交易中上漲6.3%，至12.39美元。

Also check this out: US Stock Futures Down Ahead Of Fed Speakers, Economic Data.

還有，看看這個：美國股指期貨在美聯儲發言人之前下跌，經濟數據。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論